McKesson Corporation, a leading healthcare service provider in the United States and around the world, has announced its operational structure across four major segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment offers a range of healthcare products that includes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, in addition to other healthcare solutions. Community-based oncology and other specialty practices will benefit from the supply of technology, clinical support, business solutions, and consulting services offered. Further, financial, operational, and clinical solutions to pharmacies are sold by this segment. The International division operates in 13 European nations and Canada through distributing products and services to wholesale, institutional, and retail customers. The Medical-Surgical Solutions segment helps healthcare providers with medical-surgical supply distribution, logistics, and other related services. The RxTS branch delivers innovative solutions that connect pharmacies, providers, payers, and biopharma companies to provide access to medication and improve adherence of patients to their treatments. Additionally, the company provides third-party logistics and wholesale distribution support solutions. Founded in 1833, McKesson Corporation is based in Irving, Texas.